1. Academic Validation
  2. Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma

Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma

  • Allergy. 2023 Feb;78(2):559-562. doi: 10.1111/all.15513.
Lara Ravanetti 1 Tamara Dekker 1 Lihui Guo 1 Annemiek Dijkhuis 1 Barbara S Dierdorp 1 Zuzana Diamant 2 3 4 5 Sandrine Florquin 6 René Lutter 1 7
Affiliations

Affiliations

  • 1 Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
  • 2 Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • 3 Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  • 4 Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • 5 Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
  • 6 Department of Pathology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
  • 7 Department of Pulmonary Medicine, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
Figures
Products